COVID-19 Vaccination Distribution and Situation


  • Letifa Rahmadani Medical Faculty, Universitas Lampung
  • rasmi zakiah oktarlina universitas lampung
  • agustyas tjiptaningrum universitas lampung



COVID-19, Distribution, Vaccination


Developing a safe and effective COVID-19 vaccine and getting it into people's hands is a global priority that can bring hope for ending the COVID-19 pandemic. However, the application of this vaccine can differ between countries. This study takes a close look at vaccination policies, vaccination plans, and their implementation in Indonesia which may be relevant to other developing countries. Supply constraints are one of the problems faced by developing countries, including Indonesia, especially at the beginning of the vaccination period due to relatively low coverage of vaccination plans. Limited supply from producers is one of the biggest challenges in the initial vaccination period. The plan to procure early vaccinations in Indonesia will allow Indonesia to obtain more vaccine supplies over time to cover sufficient populations to acquire immunity. Apart from the importance of vaccination distribution, the willingness of individuals to receive the COVID-19 vaccine is a major challenge in many countries. However, the demand for a COVID-19 vaccine is relatively high among the world's general population. However, skepticism is a major obstacle to efforts to control the current pandemic. To promote the equitable distribution of vaccines, it is necessary to ensure that levels of price, access and acceptance are independent of available resources among individuals and countries. This can be achieved by raising awareness about the health-protective impact of vaccines among all citizens. The issue of vaccine distribution has become critical and a significant challenge in dealing with COVID-19, a global epidemic that has turned into a national disaster. Therefore, this must be addressed immediately because it can directly increase cases of COVID-19. This literature review discusses the distribution of vaccines and the problems encountered during the process.


Guan W jie, Ni Z yi, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.

Bonavita S, Tedeschi G, Atreja A, Lavorgna L. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic. Neurol Sci. 2020;41(5):1007-1009.

Shang J, Wang Q, Zhang H, et al. The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan, China. Am J Med. 2021;134(1):e6-e14.

Coronavirus W. Dashboard| WHO coronavirus (COVID-19) dashboard with vaccination data. Published online 2021.

Daoust JF. Elderly people and responses to COVID-19 in 27 Countries. PloS One. 2020;15(7):e0235590.

Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst JRAAS. 2020;21(2).

Acharya V, Ravi V, Pham TD, Chakraborty C. Peripheral Blood Smear Analysis Using Automated Computer-Aided Diagnosis System to Identify Acute Myeloid Leukemia. IEEE Trans Eng Manag. Published online 2021.

Burgos RM, Badowski ME, Drwiega E, et al. The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution. Drugs Context. 2021;10.

Strizova Z, Smetanova J, Bartunkova J, Milota T. Principles and challenges in anti-COVID-19 vaccine development. Int Arch Allergy Immunol. 2021;182(4):339-349.

Aldilawati S, Hidayat R. Edukasi Vaksinasi COVID-19 dan Penerapan 5M Dalam Menanggulangi Penularan COVID-19 di Desa Borisallo Kabupaten Gowa. Idea Pengabdi Masy. 2021;1(02):59-63.

Shen AK, Lindstrand A, Schreiber B, O’Brien K. Optimizing the supply of vaccines for COVID-19. Bull World Health Organ. 2021;99(12):848.

Bernal JL, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. bmj. 2021;373.

World Health Organization. Vaccine Equity It’s Only Impossible until It’s Done. Published online 2022.

Mbaeyi SA. COVID-19 vaccine prioritization: Work Group considerations. Published online 2020.

Bubar KM, Reinholt K, Kissler SM, et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021;371(6532):916-921.

Buckner JH, Chowell G, Springborn MR. Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers. Proc Natl Acad Sci. 2021;118(16):e2025786118.

Kukreti S, Rifai A, Padmalatha S, et al. Willingness to obtain COVID-19 vaccination in general population: a systematic review and meta-analysis. J Glob Health. 2022;12:5006.

Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245-251.

Sallam M, Dababseh D, Eid H, et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: a study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42.

Hossain MS, Islam MS, Pardhan S, et al. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study. Plos One. 2022;17(8):e0269944.

Jabessa D, Bekele F. Willingness to receive the COVID-19 vaccine and associated factors among residents of Southwestern Ethiopia: A cross-sectional study. Patient Prefer Adherence. 2022;16:1177.

Shekhar R, Sheikh AB, Upadhyay S, et al. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines. 2021;9(2):119.

WHO. WHO Coronavirus (COVID-19) dashboard. Published online 2023

Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602(7898):664-670.

Ndugga N, Pham O, Hill L, Artiga S, Mengistu S. Early State Vaccination Data Raise Warning Flags for Racial Equity. Kais Fam Found Oakl CA USA. Published online 2021.

Bollyky TJ, Murray CJ, Reiner RC. Epidemiology, not geopolitics, should guide COVID-19 vaccine donations. The Lancet. 2021;398(10295):97-99.

Kementerian Kesehatan Republik Indonesia. Vaksinasi COVID-19 nasional. Published online 2023.

Arifin B, Anas T. Lessons learned from COVID-19 vaccination in Indonesia: experiences, challenges, and opportunities. Hum Vaccines Immunother. 2021;17(11):3898-3906.

Rzymski P, Camargo CA, Fal A, et al. COVID-19 vaccine boosters: the good, the bad, and the ugly. Vaccines. 2021;9(11):1299.

Lopes JM, Morales CC, Alvarado M, et al. Optimization methods for large-scale vaccine supply chains: a rapid review. Ann Oper Res. Published online 2022:1-23.

Jarrett S, Wilmansyah T, Bramanti Y, et al. The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring. Vaccine. 2020;38(52):8318-8325.

Sudari F, Priskilla I, Febiola M, Sinuraya RK. Strategies to improve the vaccine distribution and community awareness of taking COVID-19 vaccine in rural areas in Indonesia. Pharmacia. 2022;69(2):543-553.

Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health. 2020;65(6):711-712.

Octavius GS, Yanto TA, Heriyanto RS, Nisa H, Ienawi C, Pasai HE. COVID-19 vaccination acceptance in Jambi City, Indonesia: A single vaccination center study. Vacunas Engl Ed. 2022;23:S8-S17.

Faturohman T, Kengsiswoyo GAN, Harapan H, Zailani S, Rahadi RA, Arief NN. Factors influencing COVID-19 vaccine acceptance in Indonesia: an adoption of Technology Acceptance Model. F1000Research. 2021;10.

Cokro F. Supporting and inhibiting factors of accepting COVID-19 booster vaccination in the elderly in north Jakarta, Indonesia. Pharm Pract. 2022;20(4):1-9.



How to Cite

Letifa Rahmadani, rasmi zakiah oktarlina, & agustyas tjiptaningrum. (2023). COVID-19 Vaccination Distribution and Situation. Medical Profession Journal of Lampung, 13(2), 7-13.




Most read articles by the same author(s)

1 2 > >>